Introducing an innovative approach to spinal decompression and fusion.
The DTRAX® platform includes innovative instruments and implants used in spine surgery. The current product line is designed primarily to achieve fusion of the cervical spine.
DTRAX Spinal System is a set of single-use instruments designed for spinal fusion and compatible with a range of spinal implants. The system enables tissue-sparing access to the spine and facilitates the steps necessary to perform spinal arthrodesis.
DTRAX Cervical Cage is used to treat cervical radiculopathy caused by degenerative disc disease by providing indirect decomression of the symptomatic nerve and stabilizing the vertebral segment until fusion occurs.
DTRAX Graft is a structural allograft implanted in the facet joint to support posterior fusion. When implanted, DTRAX Graft provides an indirect decompression of the nerve roots by distracting the facets and opening the neuroforamen.
DTRAX Bone Screws are indicated for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, fracture repair, and fracture fixation appropriate for the size of the device. DTRAX Bone Screws can provide supplemental fixation to DTRAX Cervical Cage to support cervical fusion.
Cavux Surface Technology uses a proprietary subtractive process to treat the surfaces of titanium implants. It is designed to promote rapid osseointegration and provide enhanced mechanical stabilization at the implant-to-bone interface. All DTRAX implants will be available with Cavux Surface Technology.
DTRAX Expandable Cage System is a sterile, single-use kit containing all the tools and implants that are needed to perform a single level surgery. The system includes a proprietary, expandable, titanium implant that provides indirect decompression and stabilization of the vertebral segment until fusion occurs. Formerly marketed as "DTRAX Facet System"
DTRAX technology offers a less disruptive alternative for patients suffering from cervical radiculopathy.
DTRAX technology enables an innovative posterior approach (from the patient’s back) that typically requires two small incisions at the base of the patient's neck.
Patients who suffer from neck and/or arm pain due to degenerative disc disease may be treatable with spinal stabilization using DTRAX technology. Proper diagnosis of cervical radiculopathy followed by at least six weeks of conservative care is recommended before considering any surgery.
Cervical radiculopathy is characterized by:
With DTRAX technology your surgeon first relieves pressure on your spinal nerves by distracting (opening) the joints so the nerves are no longer irritated. Then two implants and graft material are inserted to enable healing of these joints.
Alternative Surgical Options
Anterior Cervical Decompression and Fusion (ACDF) - One of the most common surgeries used to treat cervical radiculopathy, ACDF removes tissue from the body and involves bone grafting and plates through the front of the neck.
Open Posterior Cervical Decompression and Fusion - The posterior approach to the cervical spine requires dissection of muscle and tissue off the spine, plus insertion of plates and screws. These surgeries typically are very painful and the injured muscles.
Artificial Disc Replacement - Indicated for a small set of patients with early onset disc degeneration.
Clinical trials studying posterior spinal fusion with DTRAX technology demonstrate that the procedure is effective at relieving neck and arm pain associated with cervical radiculopathy.1
1. Percutaneous posterior cervical fusion with the DTRAX Facet System for single-level radiculopathy: results in 60 patients. Bruce M. McCormack, Jose Manuel F. Ignacio, Rafael C. Bundoc, Sigurd H. Berven, Mario R. Ver, and Edward F. Eyster. 10.3171/2012/12.SPINE12477.
Spinal fusion with DTRAX is typically performed by a specially trained surgeon and usually takes about one hour. Published clinical data demonstrates that most patients experience rapid and lasting improvement in symptoms.Contact us to learn more about how DTRAX can improve your life.
A privately-held medical device company developing innovative solutions addressing the $1 billion worldwide cervical spine market. The company's focus is on commercializing the DTRAX platform of tissue-sparing cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression, stabilization and fusion.
David Cash (Principal, Stanmore Medical Investments)
Bruce McCormack, M.D. (Neuro Surgeon, NeuroSpine Institute Medical Group)
Robert Thomas (Managing Director, Aphelion Capital)
Jeff Smith (CEO, Providence Medical Technology)
Art Taylor (COO and CFO, Topera Inc.)
Jeff Smith (CEO, Co-Founder, Director)
Jason Hoffman (VP, Global Sales)
Edward Liou (VP, Engineering and Operations)
Neil O’Connell (VP, Finance)
NASS 30th Annual Meeting (North American Spine Society) - Booth #623
October 14-17, 2015 - Chicago, IL
Providence Medical Technology, Inc.
3650 Mt. Diablo Blvd, Suite 104
Lafayette, CA 94549
Tel: (415) 923-9376
Fax: (415) 923-9377